Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Int J Antimicrob Agents ; 31(4): 316-20, 2008 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-18180149

RESUMO

Gram-positive anaerobic cocci (GPAC) are a heterogeneous group of microorganisms frequently isolated from local and systemic infections. In this study, the antimicrobial susceptibilities of clinical strains isolated in 10 European countries were investigated. After identification of 299 GPAC to species level, the minimum inhibitory concentrations of penicillin, imipenem, clindamycin, metronidazole, vancomycin and linezolid were determined by the agar dilution method according to the Clinical and Laboratory Standards Institute. The majority of isolates were identified as Finegoldia magna and Parvimonas micra (formerly Peptostreptococcus micros), isolated from skin and soft tissue infections. All isolates were susceptible to imipenem, metronidazole, vancomycin and linezolid. Twenty-one isolates (7%) were resistant to penicillin (n=13) and/or to clindamycin (n=12). Four isolates were resistant to both agents. The majority of resistant isolates were identified as F. magna and originated from blood, abscesses and soft tissue infections.


Assuntos
Antibacterianos/farmacologia , Farmacorresistência Bacteriana , Cocos Anaeróbios Gram-Negativos/efeitos dos fármacos , Infecções por Bactérias Gram-Positivas/epidemiologia , Vigilância da População , Europa (Continente)/epidemiologia , Cocos Anaeróbios Gram-Negativos/enzimologia , Cocos Anaeróbios Gram-Negativos/genética , Infecções por Bactérias Gram-Positivas/microbiologia , Humanos , Testes de Sensibilidade Microbiana , beta-Lactamases/biossíntese , beta-Lactamases/metabolismo
2.
Ukr Biokhim Zh (1999) ; 74(3): 31-41, 2002.
Artigo em Ucraniano | MEDLINE | ID: mdl-12916235

RESUMO

It has been established that metabolism of mixed microbial population formed on easy assimilated sources of energy and nitrogen (concentrate diet) progressed on higher level. There is increase of amilolytic activity, formation of lactate, ammonia, low molecular carbonic acids with predomination of propionate molar fraction. The increased resistance to effect of pentachlorophenol (PCP) is characteristic nature of the latter. The role of the most resistant synthrophic bacteria to PCP increases. The pure strains of Streptococcus bovis and Megasphaera elsdenii do not stop metabolism at 100 microM of PCP. Mixed population of microorganisms formed on hard accessible biosubstrates (cellulose) and Butyrivibrio fibrisolvens have the increased cellulosolytic activity and while the high sensibility even to low doses of PCP (10-40 microM) is observed. It has been supposed that mechanism of PCP effect is ambiguous for various species of microbial complex of rumen. It's effect strength on all main chains of metabolism (membrane transport, energetic exchange, protein biosynthesis, etc.) significantly depends on capacity of pool of metabolic intermediates formed as a result of definite program of biotechnology of nurture, but significantly decreases the harmful effect of biocides.


Assuntos
Pentaclorofenol/farmacologia , Rúmen/microbiologia , Animais , Bovinos , Celulose/metabolismo , Meios de Cultura , Relação Dose-Resposta a Droga , Cocos Anaeróbios Gram-Negativos/efeitos dos fármacos , Cocos Anaeróbios Gram-Negativos/metabolismo , Cocos Gram-Positivos/efeitos dos fármacos , Cocos Gram-Positivos/metabolismo , Lactatos/metabolismo , Rúmen/efeitos dos fármacos , Rúmen/metabolismo , Especificidade da Espécie , Streptococcus bovis/efeitos dos fármacos , Streptococcus bovis/metabolismo , Especificidade por Substrato
3.
Otolaryngol Clin North Am ; 26(4): 549-59, 1993 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-8414527

RESUMO

This article provides an overview of the antimicrobial agents most commonly employed against the bacteria that cause infections in the ear, nose, throat, head, and neck. Because new bacterial resistances appear so regularly, as do new antibiotics, the reader is encouraged to supplement the information provided within this article with current information from the available literature. Specific treatment strategies for both acute and chronic sinusitis also are reviewed.


Assuntos
Antibacterianos/uso terapêutico , Infecções Bacterianas/tratamento farmacológico , Doenças dos Seios Paranasais/microbiologia , Sinusite/tratamento farmacológico , Antibacterianos/classificação , Antibacterianos/farmacologia , Infecções Bacterianas/microbiologia , Resistência Microbiana a Medicamentos , Feminino , Cocos Anaeróbios Gram-Negativos/classificação , Cocos Anaeróbios Gram-Negativos/efeitos dos fármacos , Cocos Anaeróbios Gram-Negativos/isolamento & purificação , Humanos , Masculino , Otorrinolaringopatias/tratamento farmacológico , Otorrinolaringopatias/microbiologia , Doenças dos Seios Paranasais/tratamento farmacológico , Sinusite/microbiologia , Streptococcus pneumoniae/efeitos dos fármacos , Streptococcus pneumoniae/isolamento & purificação , Streptococcus pyogenes/efeitos dos fármacos , Streptococcus pyogenes/isolamento & purificação
4.
J Indian Med Assoc ; 89(5): 132-4, 1991 May.
Artigo em Inglês | MEDLINE | ID: mdl-1748779

RESUMO

Of the 9 antibacterials, vancomycin alone at its break-point (optimum blood level) revealed highest (93.3%) efficacy on Gram-positive cocci. The remarkable activity of carbenicillin, chloramphenicol and vancomycin on Gram-positive cocci (95.4 to 96.9%), carbenicillin and chloramphenicol on Gram-positive bacilli (94.8% to 98.2%) and chloramphenicol on Gram-negative bacilli (95.4%) was noted by increasing their concentrations 1.5 to 2.5 times above their break-points. These (and even higher) concentration, however, showed relatively lower efficacy of metronidazole, rifampicin, penicillin, clindamycin and erythromycin on Gram-positive cocci (76 to 84.1%), rifampicin, tetracycline, erythromycin, clindamycin and vancomycin on Gram-positive bacilli (81 to 87.9%) and clindamycin, metronidazole, rifampicin and carbenicillin in Gram-negative bacilli (72.7 to 84%). By and large, rifampicin, chloramphenicol and carbenicillin are also quite effective (72.1 to 75.1%) at lower concentration.


Assuntos
Antibacterianos/farmacologia , Cocos Anaeróbios Gram-Negativos/efeitos dos fármacos , Cocos Gram-Positivos/efeitos dos fármacos , Resistência Microbiana a Medicamentos , Humanos , Testes de Sensibilidade Microbiana/métodos
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...